PM Equity Partner

What is PM Equity Partner?

PM Equity Partner (PMEP) is the corporate venture capital wing of Philip Morris International (PMI), intent on sourcing and investing in pioneering technologies and businesses that align with PMI's shift towards a smoke-free future. The fund predominantly targets sectors involving Reduced-Risk Products (RRPs), both in inhalable and oral forms, promoting alternatives to conventional smoking.

Additionally, PMEP significantly invests in self-care, wellness, social, and environmental impact ventures, reflecting a broader commitment to health and sustainability. PMEP leverages PMI's substantial global presence, accessing markets in over 180 countries and capitalizing on a robust supply chain and distribution network to foster growth in its portfolio companies.

The fund extends support to its investments through a collaborative approach, integrating PMI's expansive network which includes around 83,000 employees boasting diverse expertise and over 300 world-class scientists. PMEP's R&D Cube located in Neuchâtel is equipped with high-tech laboratories, providing a solid foundation for innovation in the field. Their long-term investment stance ensures the stability and sustainable results for their portfolio companies, which include Neuro, Comet, Biognosys, and Moodify, among others.

PMEP's strategy is grounded in innovation, market visibility from building some of the world's most valuable brands, and fostering a shared perspective on the future of technology and wellness.